Modulatory effect of bradykinin on noradrenaline release in isolated atria from normal and B2 knockout transgenic mice

European Journal of Pharmacology

Volumn 346, Issue 2-3, 1998, Pages 167-174

  Chulak, Chantal ^a   Couture, Réjean ^a   Foucart, Sylvain ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Atrium mouse; B2 knockout transgenic mouse; Bradykinin; Kinin receptor; Kininase; Noradrenaline release; Prostaglandin; Protein kinase C

Indexed keywords

3 (2 GUANIDINOETHYLTHIO) 2 (MERCAPTOMETHYL)PROPIONIC ACID; BRADYKININ; BRADYKININ ANTAGONIST; ENALAPRILAT; NORADRENALIN; PROTEIN KINASE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; FACILITATION; FEMALE; HEART ATRIUM; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSGENIC MOUSE;

ANIMALS; BRADYKININ; CYCLOOXYGENASE INHIBITORS; DICLOFENAC; ELECTRIC STIMULATION; FEMALE; HEART; LYSINE CARBOXYPEPTIDASE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; NOREPINEPHRINE; PEPTIDYL-DIPEPTIDASE A; PROSTAGLANDINS; PROTEIN KINASE C; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; UP-REGULATION;

EID: 0032502619     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00060-0     Document Type: Article

References (31)

1. 2 knockout transgenic mice. Eur. J. Pharmacol. 333:1997;55-61.
2. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 44:1992;1-80.
3. 2 receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem. 270:1995;13706-13710.
4. Burch R.M., Farmer S.G., Steranka L.R. Bradykinin receptor antagonists. Med. Res. Rev. 10(2):1990;237-269.
5. Chulak C., Couture R., Foucart S. Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria. Br. J. Pharmacol. 115:1995;330-334.
6. 9-bradykinin. Br. J. Pharmacol. 93:1988;969-977.
7. Dominiak P., Simon M., Blöchl A., Brenner P. Changes in peripheral sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and des-Arg-bradykinin infusions: influence of converting-enzyme inhibition. J. Cardiovasc. Pharmacol. 20:1992;S35-S38. Suppl. 9.
8. 1 receptors for kinins. J. Pharmacol. Exp. Ther. 259:1991;997-1003.
9. Erdös E.G. Some old and some new ideas on kinin metabolism. J. Cardiovasc. Pharmacol. 15:1990;S20-S24. Suppl. 6.
10. Hall J.M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56:1992;131-190.
11. Hock F.J., Wirth K., Albus U., Linz W., Gerhards H.J., Wiemer G., Henke S.T., Breipohl G., König W., Knolle J., Schölkens B.A. Hoe 140, a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102:1991;769-773.
12. Johnston H., Majewski H., Musgrave I.F. Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria. Br. J. Pharmacol. 91:1987;773-781.
13. Lembeck F., Griesbacher T., Eckhardt M., Henke S., Breipohl G., Knolle J. New, long-acting, potent bradykinin antagonists. Br. J. Pharmacol. 102:1991;297-304.
14. Linz W., Wiemer G., Gohlke P., Unger T., Schölkens B.A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47:1995;25-49.
15. Llona I., Galleguillos X., Belmar J., Huidobro-Toro J.P. Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals. Life Sci. 48:1991;2585-2592.
16. Maas J., Rae G.A., Huidobro-Toro J.P., Calixto J.B. Characterization of kinin receptors modulating neurogenic contractions of the mouse isolated vas deferens. Br. J. Pharmacol. 114:1995;1471-1477.
17. Majewski, H., Costa, M., Foucart, S., Murphy, T.V., Musgrave, I.F., 1990. Second messengers are involved in facilitatory but not inhibitory receptor actions at sympathetic nerve endings. In: Stanley, K., Westfall, T.C. (Eds.), Presynaptic Receptors and the Question of Autoregulation of Neurotransmitter Release. Ann. New York Acad. Sci., 604, pp. 266-275.
18. 1 receptors: a review. Immunopharmacology. 30:1995;1-26.
19. Marceau F., Lussier A., Regoli D., Giroud J.P. Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen. Pharmacol. 14:1983;209-229.
20. Minshall R.D., Yelamanchi V.P., DJokovic A., Miletich D.J., Erdös E.G., Rabito S.F., Vogel S.M. Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ. Res. 74:1994;441-447.
21. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br. J. Pharmacol. 110:1993;71-76.
22. 2 receptors in the mouse. Can. J. Physiol. Pharmacol. 73:1995;1759-1764.
23. 2 receptors in the mouse. Can. J. Physiol. Pharmacol. 75:1997;558-562.
24. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
25. Rhaleb N.-E., Dion S., Barabé J., Rouissi N., Jukic D., Drapeau G., Regoli D. Receptors for kinins in isolated arterial vessels of dogs. Eur. J. Pharmacol. 162:1989;419-427.
26. Schwieler J.H., Kahan T., Nussberger J., Hjemdahl P. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanism. Am. J. Physiol. 264:1993;E631-E637.
27. Schwieler J.H., Kahan T., Nussberger J., Hjemdahl P. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo. Acta Physiol. Scand. 152:1994;83-91.
28. Starke K., Pescar B.A., Shumacher K.A., Taube H.D. Bradykinin and postganglionic sympathetic transmission. Naunyn-Schmiedeberg's Arch. Pharmacol. 299:1977;23-32.
29. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakanes M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
30. 3H]-norepinephrine release in rat hypothalamus. Clin. Exp. Pharmacol. Physiol. 20:1993;787-791.
31. Vaz-da-Silva M., Magina S., Domingues-Costa A., Moura D., Guimaraes S. The role of the endocardium in the facilitatory effect of bradykinin on electrically-induced release of noradrenaline in rat cardiac ventricle. Br. J. Pharmacol. 118:1996;364-368.